Glaukos (GKOS) Other financing activities (2014 - 2026)
Glaukos' (GKOS) quarterly Other financing activities came in at $19.3 million in Q1 2026, up 373.54% year-on-year from $4.1 million in Q1 2025, and up 235.18% on a QoQ basis from $5.8 million in Q4 2025.
Glaukos (GKOS) Other financing activities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Other financing activities data on file, last reported at $19.3 million in Q1 2026.
- On a quarterly basis, Other financing activities rose 373.54% year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $28.7 million, a 225.74% increase from a year earlier, with the FY2025 full-year figure at $13.5 million, up 81.41% from the prior year.
- Other financing activities for Q1 2026 stood at $19.3 million, up from $5.8 million in the prior quarter.
- Over the last five years, Other financing activities for GKOS reached as high as $21.3 million in Q2 2024 and fell as low as -$22.1 million in Q4 2024.
- Historically, Other financing activities has averaged $3.3 million across 5 years, with a median of $3.7 million in 2022.
- On a YoY basis, Other financing activities climbed as much as 1200.37% in 2024 and fell as far as 441.47% in 2024.
- Year by year, Other financing activities stood at -$2.1 million in 2022, then soared by 415.15% to $6.5 million in 2023, then slumped by 441.47% to -$22.1 million in 2024, then jumped by 126.1% to $5.8 million in 2025, then soared by 235.18% to $19.3 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $19.3 million in Q1 2026, $5.8 million in Q4 2025, and -$1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.33 Mn |
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | 5.77 Mn |
| Dec 31, 2025 | 5.77 Mn |
| Sep 30, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.37 Mn |
| Jun 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.97 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | -22.09 Mn |
| Dec 31, 2024 | -22.09 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 21.31 Mn |
| Jun 30, 2024 | 21.31 Mn |
| Mar 31, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.69 Mn |
| Dec 31, 2023 | 6.47 Mn |
| Dec 31, 2023 | 6.47 Mn |